ABOS earnings: real EPS beat/miss history, analyst consensus Buy, P/E -1.18. Updated 2026-07-23.
Acumen Pharmaceuticals (ABOS) Research Hub
Acumen Pharmaceuticals (ABOS) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2.92 USD (+2.46%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.18, market cap 0.13B. This hub links to the full technical, earnings and options research available for ABOS.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.92 USD (+2.46%) |
| 52-week range | 2.1 USD – 3.34 USD |
| Trend regime | Range |
| 14-day RSI | 64.8 (Bullish) |
| Trailing P/E | -1.18 |
| Market cap | 0.13B |
| Dividend yield | 0.00% |
Available research for ABOS
Covered Call on ABOS: how it works, illustrative setup around the real 2.92 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ABOS: how it works, illustrative setup around the real 2.92 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ABOS: how it works, illustrative setup around the real 2.92 USD price, max profit/loss, breakeven and when to use it. Educational.
ABOS technical analysis: range, last 2.92 USD, RSI 64.8, 52w range 2.1 USD–3.34 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ABOS in?
Acumen Pharmaceuticals (ABOS) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ABOS in an uptrend or downtrend?
As of 2026-09-11, ABOS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ABOS's trailing P/E ratio?
ABOS's trailing P/E is -1.18, with a market cap of 0.13B. See the earnings research page for full valuation detail.